Status:
UNKNOWN
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Nonalcoholic Steatohepatitis
Liver Steatosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators hypothesize that Nigella Sativa will have an effect on Nonalcoholic Steatohepatitis and Liver Steatosis by enhancing lipophagy in the liver tissue.
Eligibility Criteria
Inclusion
- Patients suffering from Steatohepatitis
- Patients suffering from Liver Steatosis
Exclusion
- Patients suffering from viral hepatitis
- Patients with HIV infection
- Patients suffering from Wilsons Disease
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02307344
Start Date
January 1 2015
End Date
January 1 2017
Last Update
December 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100